Current concepts on the pathogenesis of systemic amyloidosis

Area of Science:

• Biochemistry and Molecular Biology
• Pathology
• Medical Research

Background:

• Amyloidosis is characterized by extracellular protein fibril deposition, leading to organ dysfunction and mortality.
• Diverse proteins can form amyloid, resulting in varied clinical manifestations.
• A common feature is the formation of insoluble beta-sheet-rich fibrils, identifiable by Congo red birefringence.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying amyloid fibril formation.
• To identify factors influencing amyloidogenicity and deposition.
• To explore the role of precursor protein characteristics and auxiliary factors in amyloidogenesis.

Main Methods:

• Analysis of protein biophysical properties influencing amyloid formation.
• Investigation of mutations affecting protein stability and intermediate states.
• Study of the role of co-factors like proteoglycans and apolipoprotein E in amyloidogenesis.
• Examination of systemic amyloidoses with renal involvement, including light-chain and beta-2-microglobulin amyloidosis.

Main Results:

• Decreased protein stability due to mutations promotes partially folded intermediates.
• These intermediates expose hydrophobic/charged residues, increasing aggregation and amyloid formation.
• Proteoglycans, amyloid P component, and apolipoprotein E are implicated in amyloid deposit initiation and persistence.

Conclusions:

• Protein structure, stability, and interactions with other molecules are critical in amyloidosis.
• Understanding these molecular processes is essential for therapeutic development.
• Further research into amyloidogenesis mechanisms is required for effective treatment strategies.